Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

633
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
633
Dose Size and Dosing Frequency: Determination Methods01:21

Dose Size and Dosing Frequency: Determination Methods

312
Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
312
Anatomy of Respiratory System II: Lower Respiratory Tract01:31

Anatomy of Respiratory System II: Lower Respiratory Tract

3.8K
The lower respiratory tract is anatomically composed of several vital structures, including the larynx, trachea, bronchial tree, alveoli, lungs, and pleurae. Each component has a specific function, and all are intricately connected to ensure efficient respiration.
The Larynx
It is located between the pharynx and the trachea, acts as a passageway for air, and hosts several critical structures, such as the epiglottis, vocal cords, and glottis. The epiglottis acts as a gateway, guiding food to the...
3.8K
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses01:25

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

246
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
246
The Respiratory System01:16

The Respiratory System

89.5K
The respiratory system is comprised of the organs that enable breathing. Air enters the nostrils and mouth, followed by the pharynx (throat) and larynx (voice box), which lead to the trachea (windpipe). In the thoracic cavity, the trachea splits into two bronchi that allow air to enter the lungs. The bronchi split into progressively smaller bronchioles and terminate in small groups of tiny sacs in the lungs called alveoli, where gas exchange occurs.
89.5K
Rational Dosage Regimen: Maintenance Dose and Loading Dose01:24

Rational Dosage Regimen: Maintenance Dose and Loading Dose

5.5K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
5.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Design and characterization of a resveratrol spray-dried inhalable formulation for pulmonary delivery with <i>in vivo</i> pharmacokinetic and toxicological evaluation.

Drug delivery·2026
Same author

In vitro comparison of aerosol deposition by albuterol pMDI using corrugated tubing versus a commercial spacer.

International journal of pharmaceutics·2026
Same author

Multi-mechanistic mitochondria-mediated N-methylated YKWYYRGAA-decorated nano-chitosan conjugate carrier for treatment of NRAS-mutant-harbouring lung carcinoma.

Carbohydrate polymers·2026
Same author

Repurposing insulin for Alzheimer's disease treatment: intranasal delivery of a thermoresponsive nanocarrier-based insulin formulation to the brain.

Drug delivery and translational research·2026
Same author

Soft‑mist inhaler spray dynamics and laryngeal deposition in upper airway models.

Expert opinion on drug delivery·2026
Same author

The Advanced Integrated Respiratory (AIR) Model: Integration of Air-Liquid Interface Cell Cultures within a Human Airway Model for Inhalation Toxicology.

Pharmaceutical research·2026

Related Experiment Video

Updated: Feb 7, 2026

Assessment of Respiratory Function in Conscious Mice by Double-chamber Plethysmography
08:58

Assessment of Respiratory Function in Conscious Mice by Double-chamber Plethysmography

Published on: July 10, 2018

44.1K

Dosing challenges in respiratory therapies.

Stewart Yeung1, Daniela Traini1, David Lewis2

  • 1Respiratory Technology, The Woolcock Institute for Medical Research and Discipline of Pharmacology, Faculty of Medicine and Health, University of Sydney, NSW 2006, Australia.

International Journal of Pharmaceutics
|July 24, 2018
PubMed
Summary

Dry powder inhalers (DPIs) now deliver high doses of medication for lung conditions like cystic fibrosis. Advanced formulations and device designs overcome particle cohesion for effective lung delivery.

Keywords:
Device designDry powder inhalerFormulation designHigh dose

More Related Videos

Evaluation of Respiratory System Mechanics in Mice using the Forced Oscillation Technique
13:10

Evaluation of Respiratory System Mechanics in Mice using the Forced Oscillation Technique

Published on: May 15, 2013

58.3K
Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration
07:59

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration

Published on: April 4, 2022

1.8K

Related Experiment Videos

Last Updated: Feb 7, 2026

Assessment of Respiratory Function in Conscious Mice by Double-chamber Plethysmography
08:58

Assessment of Respiratory Function in Conscious Mice by Double-chamber Plethysmography

Published on: July 10, 2018

44.1K
Evaluation of Respiratory System Mechanics in Mice using the Forced Oscillation Technique
13:10

Evaluation of Respiratory System Mechanics in Mice using the Forced Oscillation Technique

Published on: May 15, 2013

58.3K
Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration
07:59

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration

Published on: April 4, 2022

1.8K

Area of Science:

  • Pulmonary drug delivery
  • Inhalation technology
  • Pharmaceutical sciences

Background:

  • Pulmonary drug delivery is established for local lung conditions like asthma and COPD.
  • New technologies enable high-dose inhalation of drugs (e.g., antibiotics, insulin) for conditions like cystic fibrosis and diabetes.
  • Dry powder inhalers (DPIs) are key devices for delivering these high-dose formulations.

Purpose of the Study:

  • To review different dry powder formulations for inhalation.
  • To evaluate various DPI devices for high-dose delivery.
  • To assess the impact of formulation and device on aerosolization and lung delivery.

Main Methods:

  • Review of current literature on DPI formulations and devices.
  • Analysis of factors influencing aerosolization and de-agglomeration of high-dose powders.
  • Comparison of different DPI technologies and their performance.

Main Results:

  • High-dose dry powder formulations present challenges due to particle cohesion.
  • Advanced formulations and DPI designs are necessary to overcome cohesive forces.
  • Device design significantly impacts the dispersion and lung deposition of high-dose powders.

Conclusions:

  • Optimizing DPI formulation and device is crucial for effective high-dose pulmonary drug delivery.
  • Technological advancements are expanding the scope of inhaled therapies for systemic and local lung diseases.
  • Further research into DPI-formulation interactions is needed to improve patient outcomes.